158.274 de modificări
Bristol-Myers Squibb Company: Diferență între versiuni
Bristol-Myers Squibb Company (modificare)
Versiunea de la data 18 septembrie 2024 15:43
, 18 septembriefără descrierea modificării
Admin (discuție | contribuții) (csv2wiki) |
Admin (discuție | contribuții) Fără descriere a modificării |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei Bristol-Myers Squibb Company listata cu simbolul US.BMY | Pagina dedicata companiei Bristol-Myers Squibb Company listata cu simbolul US.BMY | ||
| Linia 5: | Linia 4: | ||
Bristol-Myers Squibb Company (www.bms.com) is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies. | Bristol-Myers Squibb Company (www.bms.com) is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies. | ||
==Grafic actiuni companie== | |||
<iframe key="tradeville" path="graficSimbol/US.BMY" /> | |||
==Ultimele stiri despre Bristol-Myers Squibb Company (US.BMY)== | ==Ultimele stiri despre Bristol-Myers Squibb Company (US.BMY)== | ||
| Linia 13: | Linia 14: | ||
addfirstcategorydate=false | addfirstcategorydate=false | ||
</dynamicpagelist> | </dynamicpagelist> | ||
[[Categorie:US.BMY]][[Categorie:Stiri despre companii]] | [[Categorie:US.BMY]][[Categorie:Stiri despre companii]] | ||